Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-aware machine learning strategies for antimicrobial peptide discovery.

Scientific reports·2024
Same author

Traditional and Computational Screening of Non-Toxic Peptides and Approaches to Improving Selectivity.

Pharmaceuticals (Basel, Switzerland)·2022
Same author

Natural product drug discovery in the artificial intelligence era.

Chemical science·2022
Same author

Machine learning-guided discovery and design of non-hemolytic peptides.

Scientific reports·2020
Same author

Predicting Blood⁻Brain Barrier Permeability of Marine-Derived Kinase Inhibitors Using Ensemble Classifiers Reveals Potential Hits for Neurodegenerative Disorders.

Marine drugs·2019

Related Experiment Video

Updated: Aug 5, 2025

Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide
07:33

Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide

Published on: December 19, 2020

6.4K

Deconstructing the Potency and Cell-Line Selectivity of Membranolytic Anticancer Peptides.

Cristina Martinez-Hernandez1, Mariana Del Carmen Aguilera-Puga1,2, Fabien Plisson1,2

  • 1Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Unidad de Genómica Avanzada, Laboratorio Nacional de Genómica para la Biodiversidad (Langebio), Irapuato, Guanajuato, 36824, Mexico.

Chembiochem : a European Journal of Chemical Biology
|March 29, 2023
PubMed
Summary

Researchers explored how anticancer peptides can be more selective for cancer cells. Increasing peptide net charge or flexibility improves selectivity between cancer cell lines, offering a path to targeted cancer therapies.

Keywords:
anticancer activitycancercell-line selectivitymembranes, peptides, potency

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.5K
In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

2.4K

Related Experiment Videos

Last Updated: Aug 5, 2025

Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide
07:33

Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide

Published on: December 19, 2020

6.4K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

12.5K
In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

2.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Current cancer treatments cause significant side effects due to damage to healthy cells and tissues.
  • There is a critical need for novel cancer therapies with enhanced selectivity for cancer cells and the ability to overcome multidrug resistance.
  • Membranolytic anticancer peptides (mACPs) show promise as a new class of anticancer agents, particularly against multidrug-resistant cancers.

Purpose of the Study:

  • To investigate the relationship between amino acid composition, physicochemical properties, sequence motifs, and sequence homology of mACPs with their potency and selectivity against various healthy and cancer cell lines.
  • To identify design principles for developing cell-line selective mACPs.
  • To understand how mACP properties influence interactions with cell membranes.

Main Methods:

  • Analysis of amino acid composition and physicochemical properties of mACPs.
  • Investigation of sequence motifs and homology within mACP sequences.
  • Evaluation of mACP potency and selectivity across a panel of healthy and cancer cell lines.
  • Correlation analysis between mACP properties and their observed biological activity.

Main Results:

  • Sequence length and net charge were identified as factors influencing mACP selectivity between cancer and healthy cell lines.
  • Increasing the net charge of mACPs enhanced their selectivity.
  • Enhanced flexibility, attributed to small and aliphatic residues, also influenced selectivity between cancer cell lines with similar lipid compositions.
  • Specific sequence motifs and homology patterns may correlate with mACP efficacy.

Conclusions:

  • The physicochemical properties of mACPs, particularly net charge and flexibility, are crucial determinants of their selectivity towards cancer cells.
  • Modulating net charge and incorporating flexible residues can guide the design of more targeted and effective anticancer peptides.
  • This research provides a foundation for developing next-generation mACPs with improved therapeutic indices and efficacy against resistant cancers.